World Pharma Today
World Pharma Today Linkedin Page World Pharma Today Facebook Page World Pharma Today Twitter Page DOWNLOAD
MEDIAPACK
Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
Mastercontrol : Improve Access to Data and Get a Competitive Edge
Latest News & Press Releases

Global Stake In The Chinese Biotech Companies Is On A Rise.

The biotechnology industry in China is coming of age as a major licencing deal has been signed between RemeGen Co Ltd and Seagen Inc, a Seattle-based company. The deal marks the biggest of all between a western company and a Chinese biotech firm.

READ MORE

Pandemic Far From Over As New Variants Keep Us On The Edge.

Looking at the present conditions, the situation looks ripe for COVID-19 to mutate into many more variants, and the assumption that the pandemic is approaching its final stage is nothing but a thought conceived by theories that no one can prove.

READ MORE

 


Nasal Covid-19 Vaccine From Bharat Biotech, A Possibility.

Bharat Biotech has been granted permission by India's drug controller to execute standalone phase 3 clinical trials on the intranasal vaccine for COVID-19. Besides this, the drug regulator has also authorised the Indian biotech giant, which is based in Hyderabad...

READ MORE

Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine Spikevax.

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced the U.S. FDA has approved the BLA for SPIKEVAX (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 18 years of age and older.

READ MORE

 


Britain To Finally Vaccinate 5-11 Year Old's Against COVID.

Britain has already been slow to vaccinate its 5-11 year olds, and they are now not vaccinating them as widely as the United States or Israel. NHS England has confirmed that children in the high-risk group will be the first to get the COVID-19 shot.

READ MORE

Novavax and Israel Announce Advance Purchase Agreement for Supply of COVID-19 Vaccine.

Novavax and Israel's Ministry of Health today announced an agreement for the purchase of NVX-CoV2373, the company's recombinant nanoparticle protein-based COVID-19 vaccine candidate with Matrix-M adjuvant.

READ MORE

 


In GSK Patent Settlement, Gilead To Pay $1.25B On Biktarvy.

It doesn't come as a shock when we hear that GlaxoSmithKline and Gilead Sciences are fighting out in HIV domain for a long time, just hoping for an access to success over the other, be it new launches or even drug trials, which have been happening round the clock.

READ MORE
 
Advertising:

kathryn@worldpharmatoday.com

Phone: + 91 88268 49084


  For the latest visit: https://www.worldpharmatoday.com/

World Pharma Today